Plain-English translation of NCT06462768 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying something called neutrophil extracellular traps — special structures made by immune cells — to understand how they may be involved in systemic sclerosis (scleroderma). By comparing blood samples from people with scleroderma, people with other autoimmune diseases, and healthy volunteers, scientists hope to learn whether these immune structures play a role in the different ways scleroderma affects patients and what complications they develop.
Scleroderma is a complex disease that affects people differently, and doctors don't yet fully understand what causes these differences or leads to serious complications. This research aims to identify a potential biological marker that could help explain disease patterns and eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will visit the hospital once to have a blood sample taken. The researchers will use this blood to isolate specific immune cells and analyze them in the laboratory. There are no medications to take, no ongoing treatments, and no follow-up visits required — just the single blood draw visit, which is similar to a routine blood test.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
France